A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

被引:12
|
作者
Eoh, Kyung Jin [1 ]
Yoon, Jung Won [1 ]
Lee, Jung-Yun [1 ]
Nam, Eun Ji [1 ]
Kim, Sunghoon [1 ]
Kim, Sang Wun [1 ]
Kim, Young Tae [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Inst Womens Med Life Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
来源
BMC CANCER | 2017年 / 17卷
基金
新加坡国家研究基金会;
关键词
Epithelial ovarian cancer; Laparoscopy; Cytoreduction surgical procedures; Debulking surgical procedures; SUBOPTIMAL PRIMARY CYTOREDUCTION; SURGERY; TOMOGRAPHY; CARCINOMA; CHEMOTHERAPY; VALIDATION; PREDICTORS; WOMEN; SCORE;
D O I
10.1186/s12885-017-3476-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). Methods: Patients diagnosed with EOC during 2012-2015 were analyzed retrospectively. Surgical and survival outcomes were compared between three treatment groups: patients without high tumor dissemination (HTD) who underwent primary debulking surgery (PDS group); patients with HTD who underwent DLS (DLS group); and patients with HTD diagnosed by cytological confirmation of malignancy followed by neoadjuvant chemotherapy (NACT group). Results: Of 181 patients, 85, 38, and 58 underwent PDS, DLS, and NACT, respectively. Among the 38 consecutive patients who initially underwent DLS, 6 were considered suitable for PDS; the remaining 32 were eligible for NACT followed by interval debulking surgery. The median operative times of debulking surgery in the PDS, DLS, and NACT groups were 365 min (interquartile range [ IQR]: 216.5-476.5 min), 266.2 min (IQR: 160.3-193. 5 min), and 339.0 min (IQR: 205-425 min; P = 0.042), respectively, with respective median estimated blood loss volumes of 962.2 mL (IQR: 300-1037.5 mL), 267.1 mL (IQR: 150-450 mL), and 861.7 mL (IQR: 150-1200 mL; P = 0.023). The DLS group had significantly reduced transfusion requirements and intensive care unit admission rates (P = 0.006). The Kaplan-Meier survival analysis indicated significantly poor PFS in the NACT group. However, there was no significant difference in OS among the three groups. Conclusions: The consecutive steps of imaging, frailty assessment, and DLS might facilitate rapid assessments of peritoneal disease extent and resectability; this novel algorithm might also be used to individualize treatment.
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [31] Optimal primary surgical treatment for advanced epithelial ovarian cancer
    Elattar, Ahmed
    Bryant, Andrew
    Winter-Roach, Brett A.
    Hatem, Mohamed
    Naik, Raj
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (08):
  • [32] Evaluation of single-port laparoscopy for peritoneal carcinomatosis assessment in advanced ovarian cancer
    Quaranta, Delphine
    Lambaudie, Eric
    Heinnemann, Mellie
    Houvenaeghel, Gilles
    Chereau, Elisabeth
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 181 : 60 - 65
  • [33] Management of advanced pancreatic cancer: Staging laparoscopy and immunochemotherapy - A new treatment strategy
    Kishiwada, M
    Kawarada, Y
    Taoka, H
    Isaji, S
    HEPATO-GASTROENTEROLOGY, 2002, 49 (48) : 1704 - 1706
  • [34] Advanced ovarian cancer, an optimal surgical treatment is possible to all patients owing to laparoscopy
    Canis, M.
    Jardon, K.
    Rabischong, B.
    Bourdel, N.
    Mage, G.
    ANNALES DE CHIRURGIE, 2006, 131 (08): : 423 - 425
  • [35] A novel frailty index is associated with sarcopenia and independently predicts survival in advanced ovarian cancer
    Kumar, A.
    DeJong, S. R.
    McGree, M.
    Weaver, A. L.
    Cliby, B. A.
    Langstraat, C. L.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 65 - 66
  • [36] Latest research and treatment of advanced-stage epithelial ovarian cancer
    Coleman, Robert L.
    Monk, Bradley J.
    Sood, Anil K.
    Herzog, Thomas J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (04) : 211 - 224
  • [37] Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
    Morrison, Jo
    Haldar, Krishnayan
    Kehoe, Sean
    Lawrie, Theresa A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (08):
  • [38] Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
    Coleridge, Sarah L.
    Bryant, Andrew
    Kehoe, Sean
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):
  • [39] TREATMENT TAILORING IN EPITHELIAL ADVANCED OVARIAN CANCER: SURVIVAL RESULTS IN NAVARRE
    Tauste Rubio, C. M.
    Zabaleta Jurio, J.
    Aguirre Gorospe, S.
    Barrenetxea Arrinda, J.
    Gaston Moreno, B.
    Muruzabal Torquemada, J. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A526 - A527
  • [40] Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
    Morrison, J.
    Swanton, A.
    Collins, S.
    Kehoe, S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04):